Important: New Login Process

We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.

  • If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
  • If you log in with a username and password, you will be prompted to set a new password before accessing your account.

Go to the Login Page to get started.

We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.

BioCentury
ARTICLE | Product Development

Departing Alnylam, Greene has messages for industry from company building to product pricing

An ‘exit interview’ with Alnylam President Barry Greene 

October 3, 2020 3:09 AM UTC

As Barry Greene departs Alnylam, he believes the modality he nurtured from plan to reality has the potential to sit alongside mAbs and small molecules as an agent of choice.

Greene announced in August that he would leave his role as president of Alnylam Pharmaceuticals Inc. (NASDAQ:ALNY) Sept. 30, after 17 years working side by side with CEO John Maraganore. ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article

BCIQ Company Profiles

Alnylam Pharmaceuticals Inc.